The potential role of biomarkers in HIV preventive vaccine trials.

Abstract

BACKGROUND Successful conduct of HIV vaccine efficacy trials entails identification and enrollment of at-risk populations, assessment of appropriate end points as measures of vaccine efficacy for prevention of HIV acquisition, and amelioration of disease course among infected vaccinees, as well as identification of potential confounders or effect modifiers… (More)
DOI: 10.1097/QAI.0b013e3181adcbbe

Topics

  • Presentations referencing similar topics